Markers of Endothelial-to-Mesenchymal Transition: Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 324-332

  Xu Dubois, Yi Chun ^a,b   Peltier, Julie ^b   Brocheriou, Isabelle ^b,c   Suberbielle Boissel, Caroline ^d   Djamali, Arjang ^e   Reese, Shannon ^e   Mooney, Nuala ^d,f   Keuylian, Zela ^a   Lion, Julien ^d,f   Ouali, Nacéra ^b   Levy, Pierre P ^b   Jouanneau, Chantal ^a   Rondeau, Eric ^a,b,c   Hertig, Alexandre ^a,b,c  

^a Urgences Néphrologiques et Transplantation Rénale Hôpital Tenon 4   (France)

^b HÔPITAL TENON   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSERM   (France)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; FASCIN; FASCIN1; HEAT SHOCK PROTEIN 47; UNCLASSIFIED DRUG; VIMENTIN; ANTIBODY; BIOLOGICAL MARKER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY MEDIATED REJECTION; ANTIBODY SPECIFICITY; ARTICLE; CAPILLARITIS; CELL MOTILITY; CELL TRANSFORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOTHELIAL TO MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; FEMALE; GLOMERULITIS; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PERITUBULAR CAPILLARITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENAL GRAFT DYSFUNCTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANTIBODIES; BIOMARKERS; ENDOTHELIUM, VASCULAR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION IMMUNOLOGY;

EID: 84954435600     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014070679     Document Type: Article

References (33)

1. Cai J, Terasaki PI: Humoral theory of transplantation: Mechanism, prevention, and treatment. Hum Immunol 66: 334-342, 2005
2. Terasaki P,Mizutani K: Antibodymediated rejection: Update 2006. Clin J Am Soc Nephrol 1: 400-403, 2006
3. Colvin RB, Smith RN: Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5: 807-817, 2005
4. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9: 2312-2323, 2009
5. Loupy A, Hill GS, Jordan SC: The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 8: 348-357, 2012
6. Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9: 2520-2531, 2009
7. El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, Cosio FG: Identifying specific causes of kidney allograft loss. Am J Transplant 9: 527-535, 2009
8. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ: Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90: 68-74, 2010
9. Sellarés J, de Freitas DG,MengelM, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF: Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12: 388-399, 2012
10. Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, LiapisH, Loupy A,Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee: Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14: 272-283, 2014
11. Jin YP, Singh RP, Du ZY, Rajasekaran AK, Rozengurt E, Reed EF: Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol 168: 5415-5423, 2002
12. Lepin EJ, Zhang Q, Zhang X, Jindra PT, Hong LS, Ayele P, Peralta MV, Gjertson DW, Kobashigawa JA, Wallace WD, Fishbein MC, Reed EF: Phosphorylated S6 ribosomal protein: A novel biomarker of antibodymediated rejection in heart allografts. Am J Transplant 6: 1560-1571, 2006
13. Jindra PT, Hsueh A, Hong L, Gjertson D, Shen XD, Gao F, Dang J, Mischel PS, BaldwinWM3rd, FishbeinMC, Kupiec-Weglinski JW, Reed EF: Anti-MHC class I antibody activation of proliferation and survival signaling inmurine cardiac allografts. J Immunol 180: 2214-2224, 2008
14. ZieglerME, Souda P, Jin YP,Whitelegge JP, Reed EF: Characterization of the endothelial cell cytoskeleton following HLA class I ligation. PLoS ONE 7: E29472, 2012
15. Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C: Inflammation-induced endothelial-tomesenchymal transition: A novel mechanism of intestinal fibrosis. Am J Pathol 179: 2660-2673, 2011
16. Zhu P, Huang L, Ge X, Yan F, Wu R, Ao Q: Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. Int J Exp Pathol 87: 463-474, 2006
17. Curci C, Castellano G, Stasi A, Divella C, Loverre A, GiganteM, Simone S, Cariello M,Montinaro V, LucarelliG, Ditonno P, BattagliaM, Crovace A, Staffieri F,Oortwijn B, van Amersfoort E,Gesualdo L,GrandalianoG: Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant 29: 799-808, 2014
18. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R: Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961, 2007
19. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R: Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19: 2282-2287, 2008
20. Murdoch CE, Chaubey S, Zeng L, Yu B, Ivetic A, Walker SJ, Vanhoutte D, Heymans S, Grieve DJ, Cave AC, Brewer AC, Zhang M, Shah AM: Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelialmesenchymal transition. J Am Coll Cardiol 63: 2734-2741, 2014
21. Wavamunno MD, O'Connell PJ, Vitalone M, Fung CL, Allen RD, Chapman JR, Nankivell BJ: Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 7: 2757-2768, 2007
22. Colvin RB: Pathology of chronic humoral rejection. Contrib Nephrol 162: 75-86, 2009
23. Haas M: Pathologic features of antibody-mediated rejection in renal allografts: An expanding spectrum. Curr Opin Nephrol Hypertens 21: 264-271, 2012
24. Sis B, Jhangri GS, Riopel J, Chang J, de Freitas DG, Hidalgo L, Mengel M, Matas A, Halloran PF: A new diagnostic algorithm for antibodymediated microcirculation inflammation in kidney transplants. Am J Transplant 12: 1168-1179, 2012
25. Halloran PF, Sellares J: Microcirculation lesions alone are not reliable for identifying antibody-mediated rejection.AmJ Transplant 13: 1931-1932, 2013
26. Menke J, Sollinger D, Schamberger B, Heemann U, Lutz J: The effect of ischemia/reperfusion on the kidney graft. Curr Opin Organ Transplant 19: 395-400, 2014
27. Dormond O, Dufour M, Seto T, Bruneau S, Briscoe DM: Targeting the intragraft microenvironment and the development of chronic allograft rejection. Hum Immunol 73: 1261-1268, 2012
28. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 8: 753-760, 2008
29. Huang G, Wilson NA, Reese SR, Jacobson LM, Zhong W, Djamali A: Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation. Am J Transplant 14: 1061-1072, 2014
30. Hertig A, Verine J, Mougenot B, Jouanneau C, Ouali N, Sebe P, Glotz D, Ancel PY, Rondeau E, Xu-Dubois YC: Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant 6: 2937-2946, 2006
31. Hertig A, Anglicheau D, Verine J, Pallet N, Touzot M, Ancel PY, Mesnard L, Brousse N, Baugey E, Glotz D, Legendre C, Rondeau E, Xu-Dubois YC: Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol 19: 1584-1591, 2008
32. HazzanM, Hertig A, Buob D, CopinMC,Noël C, Rondeau E, Dubois-Xu YC: Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients. J Am Soc Nephrol 22: 1375-1381, 2011
33. Xu-Dubois YC, Galichon P, Brocheriou I, Baugey E, Morichon R, Jouanneau C, Ouali N, Rondeau E, Hertig A: Expression of the transcriptional regulator snail1 in kidney transplants displaying epithelial-tomesenchymal transition features. Nephrol Dial Transplant 29: 2136-2144, 2014